Ask a Lawyer and Get Answers to Your Legal Questions
Yondelis is a drug marketed by Janssen Prods and is included in one NDA. There is one patent protecting this drug. This drug has thirty-eight patent family members in thirty-five countries.The generic ingredient in YONDELIS is trabectedin. There are four drug master file entries for this compound. Additional details are available on the trabectedin profile page.
Yondelis is purportedly protected under patent No. 8,895,557....and the patent is assigned to Pharma Mar, S.A., Sociedad Unipersonal (Madrid, ES)